Patent Assignment
Reel/Frame 036201/0478
Merger
Recorded: 2015-07-28
Pages: 11
Assignor
NYCOMED ASSET MANAGEMENT GMBH
Executed: 2014-10-20
Assignee
NYCOMED GERMANY HOLDING GMBH
BYK-GULDEN-STRASSE2, KONSTANZ, 78467, GERMANY
Covered Properties
(23)
Process for the rehydration of magaldrate powder
Application:
10/399,713 →
Publication:
US 2004/0018249
Process for preparing crystalline ciclesonide with defined particle size
Aqueous suspensions of ciclesonide for nebulisation
Application:
10/582,499 →
Publication:
US 2007/0117783
Use of Ciclesonide for the Treatment of Respiratory Diseases in a Smoking Patient
Application:
11/578,294 →
Publication:
US 2007/0134165
Blinding Device
Application:
11/587,945 →
Publication:
US 2007/0272236
Aqueous Pharmaceutical Preparation Comprising Roflumilast
Device for Dosing and Dry Nebulization
Device for Dosing and Dry Nebulization
Pharmaceutical Product for Injection
Application:
13/273,337 →
Publication:
US 2012/0083512
Method of Fabricating Sensors Having Functionalized Resonating Beams
Ciclesonide Containing Aqueous Pharmaceutical Composition
Application:
13/688,659 →
Publication:
US 2013/0095146
Use of Ciclesonide for the Treatment of Respiratory Diseases
Application:
13/744,962 →
Publication:
US 2013/0143849
Device and System for Delivery of an Aerosol to a Patient on Ventilatory Support
Humidified Particles Comprising a Therapeutically Active Substance
Method for Preparation of a High Concentration Liquid Formulation of an Antibody
Application:
14/068,074 →
Publication:
US 2014/0120086
Topically Applicable Pharmaceutical Preparation
Application:
14/075,035 →
Publication:
US 2014/0303215
Novel Pyrazolone-Derivatives and Their Use as Pde-4 Inhibitors
3,4,4A,10B-Tetrahydro-1H-Thiopyrano[4,3-C] Isoquinoline Compounds
Application:
14/124,446 →
Publication:
US 2014/0113877
Novel Phthalazinone-Pyrrolopyrimidinecarboxamide Derivatives
Application:
14/125,187 →
Publication:
US 2014/0112945
Formulation of an Antibody and Use Thereof
Pharmaceutical Aerosol Product for Administration by Oral or Nasal Inhalation
Novel EP2 Receptor Agonists
Pyrazolone Derivatives as PDE4 Inhibitors
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Assignment of Assignor's Interest
Feb 11, 2013
From: RAHMEL, DANIELA; TAUT, FRIEDEMANN; DE MUYNCK, CHRISTIAN; IWATSCHENKO, PETER
To: TAKEDA GMBH
Reel/Frame 029787/0430 →
Change of Name
Mar 26, 2013
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 030091/0737 →
Assignment of Assignor's Interest
Dec 2, 2013
From: RAST, MARKUS; SKUFCA, PETER; STEINHILBER, WOLFRAM; BECKER, GERHARD
To: TAKEDA GMBH
Reel/Frame 031697/0122 →
Assignment of Assignor's Interest
Dec 6, 2013
From: FLOCKERZI, DIETER; KAUTZ, ULRICH; BRAUN, CLEMENS; MANN, ALEXANDER
To: TAKEDA GMBH
Reel/Frame 031732/0801 →
Assignment of Assignor's Interest
Dec 10, 2013
From: STENGEL, THOMAS; FLOCKERZI, DIETER; HOLST, HANS CHRISTOF; MAIER, THOMAS
To: TAKEDA GMBH
Reel/Frame 031751/0642 →
Assignment of Assignor's Interest
Feb 11, 2014
From: MULLER, HELGERT; ENGELSTATTER, RENATE; BILDMANN, ULRICH; BAUER, ANDREA
To: TAKEDA GMBH
Reel/Frame 032191/0654 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0224 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0179 →
Merger
Aug 19, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036395/0557 →
Assignment of Assignor's Interest
Feb 9, 2016
From: WURST, WILHELM; BETHKE, THOMAS; ENGELSTAETTER, RENATE
To: ALTANA PHARMA AG
Reel/Frame 037690/0504 →
Change of Name
Feb 11, 2016
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 037702/0370 →
Change of Name
Feb 12, 2016
From: NYCOMED GMBH
To: TAKEDA GMBH
Reel/Frame 037809/0321 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Assignment of Assignor's Interest
Apr 17, 2017
From: TAKEDA GMBH
To: FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
Reel/Frame 042030/0371 →
Assignment of Assignor's Interest
Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Assignment of Assignor's Interest
Nov 8, 2021
From: TAKEDA GMBH
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 058043/0943 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →